All posts
-
Novo Nordisk introduces global hiring freeze
This consists of all employs that are not seriously needed to run business, the drugmaker notes. Nonetheless, the business still has 400 energetic task openings uploaded.
-
GN sees uncertainty on several fronts after reports from competitor
Unfavorable records from Italy’s Amplifon add to uncommon unpredictability in advance of GN’s 2nd quarter results on Thursday.
-
Lars Rasmussen reveals Coloplast’s focus areas: Customers and innovation in focus in new five-year plan
The advancement of brand-new items is essential for Coloplast to be able to bill greater costs and make even more cash, experts explain.
-
Navamedic’s obesity business declined in year’s first half
Sales of weight problems medication Mysimba decreased in the 2nd quarter of this year contrasted to in 2015.
-
Viking Therapeutics’ weight-loss pill disappoints in phase 2
Eli Lilli and Novo Nordisk have actually formerly offered arise from stage 3 research studies with their tablet variations.
-
Investment economist disappointed in Zealand Pharma financial results
A share buyback could confirm investors’ belief in the significant unfulfilled price potential, according to Nordnet investment economist.
-
Gold, gangs and the rise of narco-miners
Historical rate rally entices offenders and paramilitaries right into illegal mining from the Amazon to Sudan
-
Tariffs Set to Turn Holiday Shopping Season into High-Stakes Gamble
What was once the season of abundance may instead feel like one of triage, where both retailers and consumers make hard choices about what can be afforded.
